GLASSBERG ALAN 4/A
4/A · BIOGEN IDEC INC · Filed Aug 11, 2004
Insider Transaction Report
Form 4/AAmended
BIOGEN IDEC INCBIIB
GLASSBERG ALAN
Director
Transactions
- Sale
Common Stock
2004-08-04$58.02/sh−1,860$107,917→ 28,140 total - Exercise/Conversion
Stock Option (right-to-buy)
2004-08-04−13,140→ 0 totalExercise: $5.65Exp: 2008-01-02→ Common Stock (13,140 underlying) - Sale
Common Stock
2004-08-04$58.23/sh−10,000$582,300→ 3,140 total - Sale
Common Stock
2004-08-04$58.00/sh−5,000$290,000→ 23,140 total - Exercise/Conversion
sStock Option (right-to-buy)
2004-08-04−6,860→ 23,140 totalExercise: $7.79Exp: 2009-01-04→ Common Stock (6,860 underlying) - Exercise/Conversion
Common Stock
2004-08-04$5.65/sh+13,140$74,186→ 13,140 total - Sale
Common Stock
2004-08-04$58.02/sh−3,140$182,183→ 0 total - Exercise/Conversion
Common Stock
2004-08-04$7.79/sh+6,860$53,451→ 30,000 total
Footnotes (3)
- [F1]Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC rule 16(b)-3(d).
- [F2]Immediately exercisable for all the option shares on grant date of 1/2/98 subject to Issuer's repurchase rights which lapsed on 1/2/99.
- [F3]Immediately exercisable for all the option shares on grant date of 1/4/99 subject to Issuer's repurchase rights which lapsed on 1/4/2000.